I can extract side effects.

Chapter 176 The Birth of Longtu

Cao Yang's deeds of self-reliance, self-made medicine and even self-developed genetic medicine undoubtedly shocked Wei Kang greatly.

He returned to the office, still unable to fully recover from the aftershock.

Cao Yang is not only for himself, he is also running around for all the patients of Menkes disease, looking for a cure.

Even without Sanqing's intervention, Wei Kang believes that sooner or later he will overcome the difficulties and develop a genetic medicine that can completely cure the disease.

This kind of method for patients to find a way out spontaneously is actually very helpful to medical staff.

Among other things, for these 61 patients, if Sanqing were to find them by himself, it would not only be very laborious, but would also take a long time.

It has to be said that patients are inherently similar, and it is easy for a patient to find a group of fellow patients with the same patient, unite and help each other, and form a bond, thus exuding great strength.

This power is also very valuable to pharmaceutical companies.

Pharmaceutical companies need a large number of clinical patients to develop new drugs, and patients with common diseases are easy to find because of the large number.

However, for many rare diseases, the number of patients for each disease is rare, and it is very difficult to find enough clinical patients to test drugs.

Especially for rare diseases like Menkes, it is estimated that there are only 61 people in the country. If pharmaceutical companies want to find them, it is tantamount to finding a needle in a haystack.

Only a strange person like Cao Yang can bring all the patients together and save a lot of effort for pharmaceutical companies.

To some extent, patients with rare diseases and pharmaceutical companies are also interdependent and need each other.

Patients need pharmaceutical companies.

When pharmaceutical companies develop new drugs, they also need patients.

The combination of the two can completely overcome the disease and develop a cure for it.

As for the rare disease patients in China, the number of patients for each disease is not many, but the total number of patients for all diseases is very large, even surpassing the number of cancer patients, which is 2000 million.

The power of patients is very scattered, and it is difficult for pharmaceutical companies to collect them by themselves. They usually contact hospitals to find relevant patients and conduct clinical research.

This method is undoubtedly time-consuming and labor-intensive, and the efficiency is low.

Especially when the number of patients with a certain disease is extremely rare, it is even more difficult to find patients.

How can we gather all the patients and integrate them into one force to contribute to the research and development of rare diseases?

Wei Kang thought about it, and a thought kept flashing in his mind, but he couldn't grasp it.

He couldn't help but fell into deep thought.

Suddenly, he had a flash of inspiration, slammed the table, and blurted out.

"To gather 2000 million patients, is there a better way besides the Internet?"

"It is entirely possible to treat these patients as medical big data, do genetic testing for everyone, establish a personalized genetic database, and then carry out drug research and development based on genetic diseases."

"Isn't this the legendary 'personalized medicine'?"

"I have artificial intelligence in hand, am I afraid that I can't control these data?"

"In any case, having a gene bank data of 2000 million patients is already invincible."

"Afterwards, Sanqing can develop targeted gene therapy, and the cost will be paid by patients and medical insurance. Although Sanqing also has a huge investment, at least it does not have to bear it independently. This is also a basic scientific research investment, which can be regarded as an investment for future medical care."

"This is undoubtedly a win-win for patients and pharmaceutical companies, and there is even a high commercial value to be developed."

"From genetic testing, to genetic drug development, to follow-up health care, a closed medical loop has been formed. If it can be developed, there will be no shortage of payers, and a good business model will also be formed."

"If this model can be successful, it will attract a steady stream of patients, and it will inevitably create a new Internet medical model."

The more Wei Kang thought about it, the more excited he became, he turned on the computer, and began to seriously think about feasible solutions.

First of all, to create an APP, temporarily let Menkes patients join in, as well as SMA patients who have participated in clinical trials before.

After registration, the patient performs real-name authentication, associates with a medical insurance card, and then uploads his own medical records and genetic testing information.

Of course, Sanqing can also upload more detailed genetic testing data.

This forms a patient's gene database, and the patient's information about taking medicine and taking medicine can be added and saved every time he sees a doctor in the future.

This has undoubtedly formed a patient version of the electronic case. The APP can explain the relevant test data in detail, record the medication situation, and remind the patient to take the medicine on time every day.

Of course, all this information must be kept private, and cloud storage services are provided.

APP can provide personal genome services based on genetic testing, and provide personalized medical care and therapy development based on personal DNA.

If there are many patients with a certain rare disease, Sanqing can develop marketable genetic medicines, and patients can apply for clinical trial quotas on the APP.

For rare diseases, patients can adopt methods such as self-pay, crowdfunding or even installments, and contact Sanqing to develop small molecule drugs or gene drugs for individuals.

If the technology is mature, it is not very difficult at the research and development level.

The APP will also develop a forum for each rare disease, which contains information about the disease, treatment options, and even ways to make homemade medicines.

If a patient cannot obtain genetic medicine temporarily due to economic reasons or technical problems, he can obtain relevant information and pharmaceutical courses on the forum, and then make his own medicine like Cao Yang.

Even the APP can provide a shared laboratory for self-study and self-control by capable patients.

In short, if these 2000 million patients are counted as a genetic disease classification, there is a lot to do.

Not only can it greatly promote Sanqing's progress in gene therapy, but it can even greatly ease capital investment.

Of course, the development of this kind of business is definitely inseparable from the support of the state.

Moreover, if it is really going to be bigger and stronger, and if patients from all over the country are included, Sanqing may not be able to monopolize this business, and it is bound to introduce other capital.

After thinking about it, Wei Kang decided to continue.

Let’s start with the gene therapy of rare diseases first. As for the future, let’s watch as we go.

He started calling Anmi.

"Anmei, help me develop a mobile app for medical big data. The functions are as follows..."

"Okay," Anmei's sweet voice sounded: "Please name this APP."

Wei Kang pondered for three seconds: "China is the kingdom of dragons, we are all descendants of dragons, so our genome map should be called dragon map."

"Longtu, this name sounds nice."

"The Longtu APP has been completed and installed on your mobile phone. Please check and give your opinion."

"So fast!" Wei Kang quickly turned on the phone, and sure enough, an icon of a Chinese dragon flying through the clouds appeared on the desktop.

Click in, register your phone, log in, and start viewing the features.

After the real-name authentication, I quickly connected my social security card, and then put in all my previous liver cancer case information, and even took pictures of various inspection reports, and soon these information became a well-organized account in the APP. Various data.

Therefore, there is an electronic case of Weikang in the APP, which can view and print various medical images, test reports, and health data, which can be said to be very convenient.

Wei Kang nodded in satisfaction, and clicked into the forum again, but it was still blank.

He applied for two sub-versions, one for SMA disease and one for Menkes disease.

Soon, Anmei filled in some relevant information found, detailed introduction of the disease, treatment plan, Sanqing's gene medicine, and even some simple self-made medicine tutorials.

"By the way, I have to get a web version. After all, if you want to read information on the forum, the web version is more convenient."

Wei Kang suddenly remembered, and then ordered An Mei to register a new website, which was done quickly, and the link was placed in the APP forum.

"Great, let's just leave it at that, wait for patients to use it, and then continue to improve it if they have opinions."

A few days later, the Longtu branch was established, and the APP was also uploaded to the Android and fruit application stores.

The next step is to look at the patient's feedback.

(End of this chapter)